
    
      The first step (single-blind standard group) aims to verify the sensitivity of the study pain
      model in the proposed surgery to confirm the validity of the surgery according to their pain
      and enrolment rate. 12 patients are planned to be enrolled.

      The second step (dose-finding study) is a randomized, double-blind, parallel groups,
      placebo-controlled clinical trial involving a total of 104 patients divided into two groups
      in which patients will be randomized between STR-324 and placebo:

        -  Group 1: Titration initiated with a bolus

        -  Group 2: Titration without initial bolus.
    
  